Interaction Guide · Research summary

Can I take Zingiber Officinale (Ginger) Root Powder with Insulin Lispro Protamine, Human?

Review Zingiber Officinale (Ginger) Root Powder with Insulin Lispro Protamine, Human: timing and monitoring and possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Ginger powder may change average glucose control, but added hypoglycemia with insulin lispro protamine has not been established. There is also no demonstrated ginger requirement or protective spacing interval.

What this answer covers

Dried Zingiber officinale rhizome powder, marketed as root powder; extracts and oils differ. Whole Humalog premix scope.

Supplement or preparation
Zingiber Officinale (Ginger) Root Powder
Medication ingredient
insulin lispro protamine, human

The powder trial measured glucose control

An eight-week powder study reported improvements in fasting glucose and HbA1c. Its abstract does not identify a lispro-premix subgroup.

Improvement is not an adverse-event rate

Lower average glucose can benefit people whose glucose starts high. It does not itself establish a clinical low-glucose event from this combination.

The study does not establish need or spacing

It does not show that insulin creates a requirement for ginger, or that separating the supplement from an injection prevents an interaction. Powder findings cannot be assumed to apply to every extract.

Keep the prescribed mixture unchanged

Discuss the exact product and amount with the diabetes team and follow your glucose-monitoring and low-glucose treatment plan. Do not change the premix dose yourself. The protamine and soluble components have a fixed ratio and cannot be independently adjusted.

Evidence and practical considerations

Timing & monitoring

No established supplement requirement or protective spacing interval with the exact lispro premix; glucose monitoring does not demonstrate a nutrient need.

Exact scope
Dried Zingiber officinale rhizome powder, marketed as root powder; extracts and oils differ. Whole Humalog premix scope. with Insulin lispro protamine human RxCUI314684 IN within HumalogMix75/25 or50/50, SC only.
Medication form and route
subcutaneous insulin premix; oral supplement

What remains uncertain

  • Whole-product evidence does not isolate protamine component; no exact event rate or universal dose change.

Factors that may matter: Fixed ratio; Meals; Product; Dose; Other diabetes treatment.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Adults prescribed the fixed lispro premix

Hypoglycemia can be severe; niacin can reduce glucose lowering. Fixed ratio precludes separate basal/prandial dose adjustments. Inject within15minutes before a meal as labeled.

How this applies: RxCUI314684 IN insulin lispro protamine, human, as component of specified Humalog mixture.

Whole-product evidence does not isolate protamine component, compare every premix or apply to soluble lispro alone. No herb-specific adverse-event rate.

Source 2: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Adults prescribed the fixed lispro premix

Hypoglycemia can be severe; niacin can reduce glucose lowering. Fixed ratio precludes separate basal/prandial dose adjustments. Inject within15minutes before a meal as labeled.

How this applies: RxCUI314684 IN insulin lispro protamine, human, as component of specified Humalog mixture.

Whole-product evidence does not isolate protamine component, compare every premix or apply to soluble lispro alone. No herb-specific adverse-event rate.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 88participants with type 2 diabetes.

Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.

How this applies: Indirect for insulin lispro protamine within the labeled Humalog mixtures; original preparation and clinical endpoint retained.

Powder efficacy trial does not establish exact lispro-premix co-use or a hypoglycemia rate; extracts may differ.

Research assessment: · Open full citations ↗

Side effects & toxicity

Powder glucose-efficacy evidence does not establish clinical hypoglycemia during exact lispro-premix use.

Exact scope
Dried Zingiber officinale rhizome powder, marketed as root powder; extracts and oils differ. Whole Humalog premix scope. with Insulin lispro protamine human RxCUI314684 IN within HumalogMix75/25 or50/50, SC only.
Medication form and route
subcutaneous insulin premix; oral supplement

What remains uncertain

  • Whole-product evidence does not isolate protamine component; no exact event rate or universal dose change.

Factors that may matter: Fixed ratio; Meals; Product; Dose; Other diabetes treatment.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Adults prescribed the fixed lispro premix

Hypoglycemia can be severe; niacin can reduce glucose lowering. Fixed ratio precludes separate basal/prandial dose adjustments. Inject within15minutes before a meal as labeled.

How this applies: RxCUI314684 IN insulin lispro protamine, human, as component of specified Humalog mixture.

Whole-product evidence does not isolate protamine component, compare every premix or apply to soluble lispro alone. No herb-specific adverse-event rate.

Source 2: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Adults prescribed the fixed lispro premix

Hypoglycemia can be severe; niacin can reduce glucose lowering. Fixed ratio precludes separate basal/prandial dose adjustments. Inject within15minutes before a meal as labeled.

How this applies: RxCUI314684 IN insulin lispro protamine, human, as component of specified Humalog mixture.

Whole-product evidence does not isolate protamine component, compare every premix or apply to soluble lispro alone. No herb-specific adverse-event rate.

Source 3: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 88participants with type 2 diabetes.

Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.

How this applies: Indirect for insulin lispro protamine within the labeled Humalog mixtures; original preparation and clinical endpoint retained.

Powder efficacy trial does not establish exact lispro-premix co-use or a hypoglycemia rate; extracts may differ.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact protamine-lispro ingredient article with fixed-combination and original case-report limits.
Research summary published

Article revision: d0ab9c55a51202f7

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.